- Home
- EDSA vs ZCMD Comparison
EDSA vs ZCMD Comparison
Compare EDSA & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- ZCMD
- Stock Information
- Founded
- EDSA 2015
- ZCMD 2012
- Country
- EDSA Canada
- ZCMD China
- Employees
- EDSA N/A
- ZCMD N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- ZCMD Other Consumer Services
- Sector
- EDSA Health Care
- ZCMD Real Estate
- Exchange
- EDSA Nasdaq
- ZCMD Nasdaq
- Market Cap
- EDSA 6.1M
- ZCMD 6.2M
- IPO Year
- EDSA N/A
- ZCMD 2020
- Fundamental
- Price
- EDSA $1.89
- ZCMD $2.00
- Analyst Decision
- EDSA Strong Buy
- ZCMD
- Analyst Count
- EDSA 1
- ZCMD 0
- Target Price
- EDSA $21.00
- ZCMD N/A
- AVG Volume (30 Days)
- EDSA 31.2K
- ZCMD 26.5K
- Earning Date
- EDSA 02-07-2025
- ZCMD 01-01-0001
- Dividend Yield
- EDSA N/A
- ZCMD N/A
- EPS Growth
- EDSA N/A
- ZCMD N/A
- EPS
- EDSA N/A
- ZCMD N/A
- Revenue
- EDSA N/A
- ZCMD $17,406,104.00
- Revenue This Year
- EDSA N/A
- ZCMD N/A
- Revenue Next Year
- EDSA N/A
- ZCMD N/A
- P/E Ratio
- EDSA N/A
- ZCMD N/A
- Revenue Growth
- EDSA N/A
- ZCMD 1.01
- 52 Week Low
- EDSA $1.69
- ZCMD $1.00
- 52 Week High
- EDSA $5.99
- ZCMD $5.50
- Technical
- Relative Strength Index (RSI)
- EDSA 37.11
- ZCMD 61.05
- Support Level
- EDSA $1.73
- ZCMD $1.91
- Resistance Level
- EDSA $2.55
- ZCMD $1.47
- Average True Range (ATR)
- EDSA 0.18
- ZCMD 0.27
- MACD
- EDSA 0.03
- ZCMD 0.07
- Stochastic Oscillator
- EDSA 25.58
- ZCMD 61.24
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is a Cayman Islands-based provider of healthcare information, education, and training services. It provides services to healthcare professionals and the public in China. It offers online and onsite health information services, healthcare education programs, and healthcare training products, consisting of clinical practice training, open classes of popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content.